Canada markets close in 3 hours 54 minutes

Immix Biopharma, Inc. (IMMX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3570+0.0070 (+0.30%)
As of 11:54AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
8,735
8,735
4,196
126.527
248.149
Selling General and Administrative
7,406
7,406
4,023
1,225
205.703
Total Operating Expenses
16,141
16,141
8,219
1,352
453.852
Operating Income or Loss
-16,141
-16,141
-8,219
-1,352
-453.852
Interest Expense
0
0
0.497
179.853
101.976
Total Other Income/Expenses Net
-
-
-
-22,846
-574.488
Income Before Tax
-15,569
-15,569
-8,219
-24,378
-1,130
Income Tax Expense
26.415
26.415
10.268
6.013
17.547
Income from Continuing Operations
-15,596
-15,596
-8,230
-24,384
-1,148
Net Income
-15,426
-15,426
-8,230
-24,384
-1,148
Net Income available to common shareholders
-15,426
-15,426
-8,230
-24,384
-1,148
Basic EPS
-0.92
-
-0.59
-6.64
-0.13
Diluted EPS
-0.92
-
-0.59
-6.64
-0.13
Basic Average Shares
15,374
-
13,887
3,673
8,775
Diluted Average Shares
15,374
-
13,887
3,673
8,775